Equally importantly, FGFBP1 can promote hepatocellular carcinoma metastasis [38], and patients with pancreatic cancer who express higher FGFBP1 levels have been shown to have a worse prognosis [39]. This evidence concerns the gene FGFBP1 and familial pancreatic carcinoma.